Ronald Shazer
About Ronald Shazer
Ronald Shazer serves as the Executive Medical Director at Mirati Therapeutics, a position he has held since 2019. He has extensive experience in oncology clinical research, having previously worked in leadership roles at several pharmaceutical companies including Bristol-Myers Squibb, Pfizer, and TRACON Pharmaceuticals.
Current Role at Mirati Therapeutics
Ronald Shazer serves as the Executive Medical Director at Mirati Therapeutics, a position he has held since 2019. In this role, he is responsible for overseeing clinical development strategies and ensuring the advancement of innovative therapies in oncology. His leadership contributes to the company's mission of developing targeted treatments for cancer patients.
Previous Experience in Oncology Research
Prior to his current position, Ronald Shazer held several significant roles in the field of oncology research. He worked at Bristol-Myers Squibb as Director of Oncology Global Clinical Research from 2011 to 2013. He later served as Chief Medical Officer at TRACON Pharmaceuticals from 2015 to 2016 and at Denovo Biopharma from 2017 to 2019. Additionally, he was Senior Director at Pfizer, focusing on clinical lead responsibilities in oncology from 2013 to 2015.
Educational Background
Ronald Shazer earned his Doctor of Medicine (MD) degree from New York Medical College, completing his studies from 1997 to 2001. He also holds a Master of Business Administration (MBA) from the University of California, Los Angeles - The Anderson School of Management, where he studied from 2005 to 2007. His undergraduate education includes a Bachelor of Arts (BA) degree from UC San Diego, completed from 1991 to 1993.
Clinical and Academic Positions
In addition to his industry roles, Ronald Shazer has held academic positions. He served as an Assistant Clinical Professor and Physician at UCSD Medical Center from 2009 to 2011. He also worked as a Faculty Physician in the Department of Internal Medicine at Cedars-Sinai Medical Center from 2004 to 2007. These roles highlight his commitment to both clinical practice and education in the medical field.
Career Progression in Clinical Development
Ronald Shazer has a diverse background in clinical development, having worked at various pharmaceutical companies. He was Director of Clinical Research at Exelixis from 2008 to 2009 and held multiple positions at Arena Pharmaceuticals, including Director of Clinical Development and Interim Head of Clinical Development from 2009 to 2011. His extensive experience reflects a strong focus on advancing clinical research in oncology.